BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 16627257)

  • 21. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
    Hasegawa M; Sato S; Yanaba K; Komura K; Yamazaki M; Takehara K
    Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
    Front Immunol; 2021; 12():754469. PubMed ID: 34790198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
    Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
    Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome].
    Kaburaki J; Kuwana M; Kameda H; Takeuchi T; Okada J; Katayama M; Yoshida S; Ikeda Y
    Rinsho Ketsueki; 2005 Jan; 46(1):19-21. PubMed ID: 16708913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel ELISA system for simultaneous detection of six subclasses of anti-phospholipid antibodies for prediction of thrombotic complications among SLE patients.
    Nojima J; Motoki Y; Aoki N; Tsuneoka H; Ichihara K
    Thromb Res; 2014 Jun; 133(6):1135-40. PubMed ID: 24721837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.